DWT
BMY icon

Dorsey & Whitney Trust’s Bristol-Myers Squibb BMY Stock Holding History

Dorsey & Whitney Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
36,187
+2,518
+7% +$147K 0.12% 165
2025
Q4 		$1.82M Sell
33,669
-236
-0.7% -$11.4K 0.1% 173
2025
Q3 		$1.53M Buy
33,905
+431
+1% +$20.1K 0.08% 199
2025
Q2 		$1.55M Sell
33,474
-2,074
-6% -$102K 0.08% 198
2025
Q1 		$2.17M Buy
35,548
+260
+0.7% +$15.2K 0.13% 150
2024
Q4 		$2M Buy
35,288
+2,247
+7% +$126K 0.11% 166
2024
Q3 		$1.71M Buy
33,041
+10,465
+46% +$491K 0.09% 180
2024
Q2 		$938K Sell
22,576
-3,888
-15% -$174K 0.06% 235
2024
Q1 		$1.44M Sell
26,464
-1,964
-7% -$100K 0.1% 174
2023
Q4 		$1.46M Buy
28,428
+3,063
+12% +$161K 0.11% 167
2023
Q3 		$1.47M Sell
25,365
-1,692
-6% -$104K 0.13% 147
2023
Q2 		$1.73M Sell
27,057
-492
-2% -$33K 0.14% 139
2023
Q1 		$1.91M Sell
27,549
-294
-1% -$20.7K 0.17% 121
2022
Q4 		$2M Buy
27,843
+1,448
+5% +$109K 0.19% 116
2022
Q3 		$1.88M Sell
26,395
-785
-3% -$56.9K 0.2% 122
2022
Q2 		$2.09M Buy
27,180
+134
+0.5% +$10.2K 0.21% 107
2022
Q1 		$1.98M Buy
27,046
+1,093
+4% +$73.4K 0.17% 122
2021
Q4 		$1.62M Sell
25,953
-254
-1% -$14.9K 0.14% 147
2021
Q3 		$1.55M Buy
26,207
+1,170
+5% +$77.1K 0.14% 140
2021
Q2 		$1.67M Sell
25,037
-5,718
-19% -$373K 0.16% 134
2021
Q1 		$1.94M Sell
30,755
-1,467
-5% -$91.3K 0.19% 115
2020
Q4 		$2M Sell
32,222
-407
-1% -$25K 0.23% 102
2020
Q3 		$1.97M Sell
32,629
-809
-2% -$48.7K 0.26% 97
2020
Q2 		$1.97M Buy
33,438
+302
+0.9% +$18.1K 0.28% 95
2020
Q1 		$1.85M Buy
33,136
+526
+2% +$32.1K 0.31% 80
2019
Q4 		$2.09M Buy
32,610
+4,488
+16% +$257K 0.28% 91
2019
Q3 		$1.43M Buy
28,122
+874
+3% +$41.1K 0.21% 108
2019
Q2 		$1.23M Buy
27,248
+1,494
+6% +$69.6K 0.19% 114
2019
Q1 		$1.23M Buy
25,754
+804
+3% +$40K 0.19% 111
2018
Q4 		$1.3M Sell
24,950
-418
-2% -$22.5K 0.23% 101
2018
Q3 		$1.57M Sell
25,368
-3,161
-11% -$188K 0.24% 98
2018
Q2 		$1.58M Buy
28,529
+298
+1% +$16.1K 0.27% 97
2018
Q1 		$1.78M Sell
28,231
-3,911
-12% -$252K 0.33% 73
2017
Q4 		$1.97M Sell
32,142
-3,907
-11% -$244K 0.36% 67
2017
Q3 		$2.3M Buy
36,049
+2,774
+8% +$162K 0.46% 58
2017
Q2 		$1.85M Sell
33,275
-1,120
-3% -$60.9K 0.37% 66
2017
Q1 		$1.87M Buy
34,395
+5,554
+19% +$305K 0.38% 68
2016
Q4 		$1.69M Sell
28,841
-7
-0% -$383 0.38% 67
2016
Q3 		$1.56M Sell
28,848
-1,868
-6% -$120K 0.36% 67
2016
Q2 		$2.26M Buy
30,716
+30
+0.1% +$2.12K 0.52% 51
2016
Q1 		$1.96M Buy
30,686
+106
+0.3% +$6.68K 0.49% 52
2015
Q4 		$2.1M Buy
30,580
+556
+2% +$36.7K 0.56% 49
2015
Q3 		$1.78M Sell
30,024
-808
-3% -$51.3K 0.5% 53
2015
Q2 		$2.05M Sell
30,832
-3,894
-11% -$257K 0.52% 50
2015
Q1 		$2.24M Sell
34,726
-1,371
-4% -$85.8K 0.57% 48
2014
Q4 		$2.13M Sell
36,097
-653
-2% -$36.8K 0.55% 50
2014
Q3 		$1.88M Sell
36,750
-273
-0.7% -$13.6K 0.51% 55
2014
Q2 		$1.8M Sell
37,023
-3,810
-9% -$188K 0.39% 54
2014
Q1 		$2.12M Buy
40,833
+1,318
+3% +$70.1K 0.49% 49
2013
Q4 		$2.1M Buy
39,515
+1,193
+3% +$60.8K 0.57% 49
2013
Q3 		$1.77M Buy
38,322
+820
+2% +$36K 0.53% 51
2013
Q2 		$1.68M Buy
+37,502
New +$1.63M 0.56% 49

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dorsey & Whitney Trust's BMY Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Bristol-Myers Squibb (BMY) stake by 7.5% in Q1 2026, buying an estimated $147K and bringing the position to 36,187 shares worth $2.19M. The position accounts for 0.12% of the portfolio, ranked #165.

Dorsey & Whitney Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.3M in Q3 2017. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Dorsey & Whitney Trust held 36,187 shares of Bristol-Myers Squibb worth $2.19M as of Q1 2026.
  • Dorsey & Whitney Trust bought 2,518 Bristol-Myers Squibb shares in Q1 2026, an estimated $147K.
  • Bristol-Myers Squibb made up 0.12% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #165 holding.
  • Dorsey & Whitney Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Dorsey & Whitney Trust's Bristol-Myers Squibb position peaked at $2.3M in Q3 2017.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.